|
Sep 9
|
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
|
|
Sep 8
|
AOC Has It Right on CEO David Zaslav’s Pay
|
|
Sep 8
|
Kenvue, the J&J Healthcare Spinoff, Has Disappointed Investors
|
|
Sep 7
|
Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
|
|
Sep 7
|
Kenvue Stock Falls 6%. It May Be Fears on Tylenol Lawsuits.
|
|
Sep 7
|
Warren Buffett Dividend Stocks by Sectors and Industries
|
|
Sep 7
|
Healthcare Stocks Push the Dow Higher
|
|
Aug 21
|
Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS
|
|
Aug 21
|
Is Johnson & Johnson's Stock Fairly Valued? A Comprehensive Analysis
|
|
Aug 21
|
Momentum Mondays: Stocks Setting up for an Epic Dip Buying Opportunity?
|
|
Aug 21
|
11 Most Profitable Biotech Stocks Today
|
|
Aug 21
|
Tupperware, Kenvue, Earthstone Energy: Market Movers
|
|
Aug 21
|
J&J’s Kenvue Exchange Offer Was Too Popular. What Happens to Shares Now.
|
|
Aug 21
|
5 Large Drug Stocks to Watch as New Drug Approvals & M&A Gain Pace
|
|
Aug 21
|
J&J says it will retain 9.5% stake in Kenvue carve-out after exchange offer
|
|
Aug 21
|
Fed’s Powell Will Walk an Economic Tightrope. Why Markets May Not Like It.
|
|
Aug 21
|
J&J to hold 9.5% stake in Kenvue after share exchange offer
|
|
Aug 21
|
Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
|
|
Aug 20
|
10 Stocks ChatGPT Said Will Make Me Rich in 10 Years
|
|
Aug 20
|
Warren Buffett’s 11 Growth Stock Picks
|